Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 56Triple Negative Breast Neoplasms 28Lung Neoplasms 12Prostatic Neoplasms 10Neoplasm Metastasis 10Carcinoma, Intraductal, Noninfiltrating 10Anatomic Stage I Breast Cancer AJCC v8 9Carcinoma, Non-Small-Cell Lung 8Breast Carcinoma In Situ 8Ovarian Neoplasms 6Melanoma 6Stomach Neoplasms 5Pancreatic Neoplasms 5Meningeal Carcinomatosis 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Multiple Myeloma 4Colonic Neoplasms 4Brain Neoplasms 4Anatomic Stage IV Breast Cancer AJCC v8 4Small Cell Lung Carcinoma 3Inflammatory Breast Neoplasms 3Esophageal Neoplasms 3Endometrial Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Obesity 2

Interventions

trastuzumab biosimilar HLX02 1exemestane 1X-Rays 1Trastuzumab 1Taxes 1TVB-2640 1Specimen Handling 1Paclitaxel 1PF-05280014 1Ontruzant 1Ogivri 1Magnetic Resonance Spectroscopy 1Letrozole 1Fulvestrant 1Disulfides 1CT-P6 1Biopsy 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Breast Carcinoma × Specimen Handling × Breast × Clear all
NCT03179904 2026-05-05

TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

Mayo Clinic

Phase 2 Active not recruiting
17 enrolled 10 charts
Breast

Advanced Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡